Is Yatharth Hospit. overvalued or undervalued?

As of 6 October 2025, the valuation grade for Yatharth Hospital has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company appears to be overvalued at this time. Key ratios include a PE Ratio of 52.96, an EV to EBITDA of 30.41, and a Price to Book Value of 4.69, all of which are considerably high compared to industry norms.
In comparison to its peers, Yatharth Hospital's PE Ratio of 52.96 is lower than Apollo Hospitals at 69.82 but higher than Narayana Hrudaya at 46.2. Additionally, while Yatharth's EV to EBITDA of 30.41 is more favorable than Max Healthcare's 56.77, it still reflects a high valuation relative to the broader market. Notably, Yatharth Hospital has outperformed the Sensex with a year-to-date return of 38.08% compared to the Sensex's 4.67%, reinforcing the notion of its current overvaluation.